The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: 0.00 (0.00%)
Spread: 0.10 (10.00%)
Open: 1.05
High: 1.05
Low: 1.05
Prev. Close: 1.05
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Formation of new Scientific Advisory Group

21 Oct 2013 07:00

RNS Number : 9004Q
Microsaic Systems plc
21 October 2013
 



21 October 2013

Microsaic Systems plc

("Microsaic" or the "Company")

Microsaic Systems announces prestigious new Scientific Advisory Group

High profile group members drawn from research and industry

Microsaic Systems plc (AIM: MSYS), the high technology company developing next-generation mass spectrometry instruments, announces the formation of its first Scientific Advisory Group. Colin Jump, CEO Microsaic Systems, commented, "With the successful international launch and showcasing of our premier product, the 4000 MiD, we have created a real interest in our growing portfolio of innovative chip-based technology. Moving forward we have now been able to draw on the extraordinary pool of expertise in the UK analysis and mass spectrometry arena to form a highly experienced Scientific Advisory Group. The members have impressive credentials across all areas of industry and research and will be able to advise us on realistic future applications for our chip-based technology."

 

The majority of the advisory group come from industry and research backgrounds, comprising the Chair: Dr Steve Lane, C.Chem, FRSC, Founder & Director of SJL Strategic Sciences and former Global VP Analytical Chemistry at GSK; Prof Frank Pullen, PhD, CSci, C.Chem, FRSC, Professor of Pharmaceutical Analysis, University of Greenwich and former Senior Director of Discovery Analytical Sciences at Pfizer, UK; Mr Richard Fussell, Senior Analytical Chemist in the Chemical Safety Programme of Food and Environment Research Agency (FERA); Dr Anthony Bristow, Associate Principal Scientist, Astra Zeneca and Chair BMSS; Dr Andrew Ray, Associate Principal Scientist, AstraZeneca; Dr John Langley, Head of Characterisation and Analytics, University of Southampton; Dr Neil Spooner, C.Chem, MRSC, Director, Bioanalytical Science & Development, PTS DMPK, GSK; Dr Donald Daley, Senior Director of DMPK & Physical Sciences, Argenta Discovery and former Department Director, Global Physical Chemistry and Structural Chemistry, Rhone Poulenc Rorer; and Prof Eric Yeatman, Director and co-founder of Microsaic Systems plc and Professor of Microengineering, Imperial College London. The remaining members are drawn from Microsaic's senior management: Mr Colin Jump, CEO; Mr Peter Edwards, Technical Director, Dr Steven Wright, Principal Scientist; and Mr Jeremy Reddish, Business Development Manager.

 

As well as helping to position Microsaic scientifically, the advisory group will advise on high impact areas of application for miniaturised mass spectrometry (MS) and MS/MS and their efficient interfacing with separation front ends to help Microsaic understand the requirements for success in these application areas. The group will also consider the synergy between application and technology, defining the importance of the application and what technology/ performance improvements are necessary to deliver miniaturised technology and help advise on opportunities for collaborative projects.

 

-ends-

Contacts

Microsaic Systems

Colin Jump, CEO

Via Citigate Dewe Rogerson

 

Numis Securities Limited

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

 

+44 (0)20 7260 1000

 

Citigate Dewe Rogerson (Financial PR)

Mark Swallow, Malcolm Robertson, Chris Gardner

 

+44 (0)20 7282 2948/2867/2995

 

 

Conscience Creative (Trade PR)

Reita Smith

 

+44 (0)20 3475 4226

 

About Microsaic Systems

Microsaic Systems develops and sells chip-based scientific instruments for the chemical identification of substances. The Company's products are based on the 'gold-standard' scientific technique of mass spectrometry.

Microsaic Systems has developed a miniaturised mass spectrometer based on its patented, chip-based technologies (ionchip®, spraychip® and vac-chip™), that is smaller, lighter, quieter, more energy efficient and cheaper to run than conventional mass spectrometer systems.

Mass spectrometry is used across many industry sectors, including government, energy, utilities, pharmaceutical, diagnostics and healthcare, environmental, food and drink, security and defence, and industrial chemicals - a combined market of $3 billion in 2012.

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS.

www.microsaic.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEALEPFDFDFFF
Date   Source Headline
14th Sep 20163:38 pmRNSGrant of Options
13th Sep 20164:46 pmRNSHolding(s) in Company
13th Sep 201610:45 amRNSHolding(s) in Company
13th Sep 20168:40 amRNSHolding(s) in Company
13th Sep 20168:30 amRNSDirector/PDMR Shareholding
12th Sep 201611:53 amRNSResult of GM, Completion of Placing, TVRs
26th Aug 20164:49 pmRNSResult of Placing
26th Aug 20161:15 pmRNSProposed Placing of New Shares
26th Aug 20161:15 pmRNSHalf-year Report
20th Jun 20163:27 pmRNSAGM Statement
13th Jun 20167:00 amRNSChange of Nominated Adviser and Broker
19th May 20167:00 amRNSDistribution of Annual Report and Accounts
13th May 201612:57 pmRNSAGM Change of Date
16th Mar 20167:00 amRNSAnnual Financial Report
8th Mar 20167:00 amRNSDirectorate Change
24th Feb 20167:00 amRNSTrading Statement
14th Jan 20167:00 amRNSAward of Options
21st Dec 20157:00 amRNSDirectorate Change
2nd Dec 20157:04 amRNSTrading Update & Directorate Change
30th Nov 201511:47 amRNSHolding(s) in Company
23rd Oct 201511:41 amRNSHolding(s) in Company
22nd Oct 20151:12 pmRNSHolding(s) in Company
19th Oct 20151:37 pmRNSResults of EGM and Placing
15th Oct 20157:00 amRNSPlacing - Exercise of Additional Demand Option
13th Oct 20153:30 pmRNSDirector/PDMR Shareholding
30th Sep 20157:44 amRNSPlacing of New Shares
30th Sep 20157:00 amRNSInterim Results
20th May 20157:00 amRNSResult of AGM
8th Apr 20158:34 amRNSNotification of Major Interest in Shares
30th Mar 20157:00 amRNSDistribution of Annual Report and Accounts
23rd Mar 20157:00 amRNSAnnual Financial Report
19th Mar 20157:00 amRNSAppoinment of Chief Operating Officer
16th Mar 20157:00 amRNSOEM Supply Agreement with GE Healthcare
6th Jan 20158:40 amRNSExercise of Share Options
28th Oct 20149:16 amRNSHolding(s) in Company
14th Oct 20142:10 pmRNSHolding(s) in Company
10th Oct 20144:19 pmRNSHolding(s) in Company
10th Oct 20141:15 pmRNSExercise of Share Options
8th Oct 20147:00 amRNSDirectors' Dealings
7th Oct 20147:00 amRNSConditional Placing to Raise £4.4 million
30th Sep 20147:00 amRNSInterim Results
29th Sep 201412:23 pmRNSCommercial Agreement with Gilson Inc.
25th Sep 20147:00 amRNSMicrosaic Systems Signs Commercial Agreement
9th Sep 20147:00 amRNSPlexus chosen as commercial manufacturing partner
15th Jul 201410:06 amRNSDirectorate Change
23rd Jun 20143:08 pmRNSHolding(s) in Company
19th Jun 201412:02 pmRNSHolding(s) in Company
13th Jun 20149:00 amRNSDISTRIBUTION OF ANNUAL REPORT & ACCOUNTS
10th Jun 20149:10 amRNSExercise of share options
3rd Jun 20147:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.